News

Collaboration agreement to investigate the clinical use of the Parsortix system for breast cancer.

Ms. Tanner appointed as independently-acting member and as Audit Committee chairman.

Techniques that extend the observation of crystals beyond the optical microscope will enhance structural biology in the future.

The article presents the first proof-of-principle results from fixed-target serial crystallography using the Linac Coherent Light Source.

Selection for the accolade shortlist recognizes the company’s mDNA® technology project team - leading the way with innovation in the field of patient engagement and data capture solutions to enhance efficiencies in clinical trials.

Government will fund 125 PhD students through the Norwich Research Park Doctoral Training Partnership over the next five years.

Leading supplier of 3D microtissues for in vitro toxicity and efficacy testing earns top honors in annual Swiss startup competition.

Addition of Spinnovation expands and strengthens Company’s chemical R&D group.

Common Cents Systems, Inc. and Indigo Biosystems collaborate to create improved approach to clinical toxicology and reference lab LC/MS data processing and results reporting.

Experimental therapy stopped the metastasis of breast and ovarian cancers in lab mice, pointing toward a safe and effective alternative to chemotherapy.